Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of New Immunopathogenic Mechanisms Associated With LRBA or CTLA4 Deficiencies

NCT04377867 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT04377867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04377867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of New Immunopathogenic Mechanisms Associated With LRBA or CTLA4 Deficiencies
Lead sponsor
Marmara University
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2020
Completion date
January 15, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctla4 haploinsufficiency, lrba deficiency